Positive Outlook for Alpha Teknova: Consistent Revenue Growth and Strategic Expense Management Drive Buy Rating
I'm PortAI, I can summarize articles.
William Blair analyst Matt Larew has reiterated a Buy rating on Alpha Teknova (TKNO) stock, citing consistent revenue growth and effective expense management. The company reported a 9% revenue increase for the fifth consecutive quarter, while maintaining operating expenses below $8 million for six quarters. Positive trends in biotech funding and the pharmaceutical sector enhance Teknova's outlook, aiming for adjusted EBITDA breakeven by 2026. TD Cowen also supports a Buy rating with a $7.00 price target.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments